Search

everythinglearnresearchcommunity

for

Search:↓

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hair from balding and non-balding areas regrows similarly on mice.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Adiantum capillus extract reduces pain and swelling in animals.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Polymeric nanoparticles show promise for treating skin diseases.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.